EUVIMEDEUVIMED entdecken
Crossref

MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth

N. Badesra

European Journal of Cancer · 2026-11 · 248 · 117596

DOI: 10.1016/j.ejca.2026.117596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von N. Badesra.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Badesra, N. (2026). MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth. European Journal of Cancer, 248, 117596. https://doi.org/10.1016/j.ejca.2026.117596

Vancouver

Badesra N. MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth. European Journal of Cancer. 2026;248:117596. doi:10.1016/j.ejca.2026.117596

BibTeX
@article{Badesra2026,
  author = {Badesra, N.},
  title = {MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117596},
  doi = {10.1016/j.ejca.2026.117596}
}
Kostenlos starten →